Summary

Japan Singleplex Immunoassay Market Research Report By Product and Service (Consumables, Instruments, Others), By Type (Protein-Based Assays, Nucleic Acid Based Assays, Cell-Based Assays, Others), By Technology (Flow Cytometry, Fluorescence Detection), By Application (Research & Development, Drug Discovery & Development, Biomarker Discovery & Validation, Clinical Diagnostics, Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Metabolism and Endocrinology Disorders, Others) and By End-user (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others) - Growth & Industry Forecast 2025 To 2035

Market Summary:
As per Market Research Future analysis, the Japan singleplex immunoassay market size was estimated at 9.85 USD Million in 2024. The Japan singleplex immunoassay market is projected to grow from 10.18 USD Million in 2025 to 14.08 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 3% during the forecast period 2025 - 2035

Market Drivers:
The growing emphasis on personalized medicine in Japan is influencing the singleplex immunoassay market. As healthcare providers aim to tailor treatments to individual patients, the need for specific biomarker detection becomes paramount. Singleplex immunoassays facilitate this by allowing for the precise measurement of targeted analytes, which is essential for developing personalized treatment plans. The market is likely to expand as pharmaceutical companies and research institutions increasingly rely on these assays for drug development and clinical trials. This trend may lead to a market valuation exceeding $600 million by 2030, as the demand for personalized healthcare solutions continues to rise. Government initiatives aimed at enhancing healthcare infrastructure in Japan are positively impacting the singleplex immunoassay market. Increased funding for research and development in diagnostic technologies is fostering innovation and encouraging the adoption of advanced testing methods. The Japanese government has been actively promoting initiatives to improve disease detection and management, which aligns with the capabilities of singleplex immunoassays.

Market Segment Analysis:
In the Japan singleplex immunoassay market, the product and service segment is dominated by consumables, which hold a significant market share. The prevalence of consumables is driven by their critical role in conducting immunoassays, supplying necessary reagents and components that laboratories depend on for accurate results. Instruments follow as an important segment, marked by increasing technological advancements that enable enhanced assay performance. Growth trends indicate that instruments are becoming the fastest-growing segment due to innovations in design and functionality, which address the evolving needs of clinical laboratories. Factors such as increased demand for rapid diagnosis and improved automation capabilities in immunoassays are propelling the growth of this segment. The shift towards more sophisticated instruments represents a fundamental change in laboratory practices, aligning them with contemporary diagnostic requirements.

Regional Analysis:
The singleplex immunoassay market is currently experiencing notable growth, driven by advancements in diagnostic technologies and increasing demand for precise and rapid testing solutions. In Japan, the healthcare sector is increasingly adopting these assays due to their ability to provide accurate results for various diseases, including infectious and chronic conditions. The integration of automation and digital technologies into laboratory processes is enhancing the efficiency of testing, thereby attracting more healthcare facilities to invest in singleplex immunoassay systems. Furthermore, the aging population in Japan is contributing to a higher prevalence of diseases, which in turn fuels the need for effective diagnostic tools.

Major Players:
The following companies are key participants in the Japan Singleplex Immunoassay Market, playing a crucial role in market development through technological innovation, strategic partnerships, and competitive product offerings.

ページTOPに戻る

Table of Contents

TABLE OF CONTENT
1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
EXECUTIVE SUMMARY
Market Overview
Key Findings
Market Segmentation
Competitive Landscape
Challenges and Opportunities
Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
MARKET INTRODUCTION
Definition
Scope of the study
Research Objective
Assumption
Limitations
RESEARCH METHODOLOGY
Overview
Data Mining
Secondary Research
Primary Research
Primary Interviews and Information Gathering Process
Breakdown of Primary Respondents
Forecasting Model
Market Size Estimation
Bottom-Up Approach
Top-Down Approach
Data Triangulation
Validation
3 SECTION III: QUALITATIVE ANALYSIS
MARKET DYNAMICS
Overview
Drivers
Restraints
Opportunities
MARKET FACTOR ANALYSIS
Value chain Analysis
Porter's Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of New Entrants
Threat of Substitutes
Intensity of Rivalry
COVID-19 Impact Analysis
Market Impact Analysis
Regional Impact
Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
Healthcare
Market Segmentation
Japan Healthcare By Application (USD Million, 2025-2035)Clinical Diagnostics
Research and Development
Drug Discovery
Environmental Testing
Healthcare By End Use (USD Million, 2025-2035)Hospitals
Diagnostic Laboratories
Pharmaceutical Companies
Academic Institutions
Healthcare
Japan By Technology (USD Million, 2025-2035)Enzyme-Linked Immunosorbent Assay
Lateral Flow Assay
Fluorescent Immunoassay
Chemiluminescent Immunoassay
Healthcare By Product Type (USD Million, 2025-2035)Kits
Reagents
Instruments
Software
Healthcare By Target Analyte (USD Million, 2025-2035)Proteins
Hormones
Antibodies
Pathogens SECTION V: COMPETITIVE ANALYSIS
Competitive Landscape
Overview
Competitive Analysis
Market share Analysis
Major Growth Strategy in the singleplex immunoassay market
Competitive Benchmarking
Leading Players in Terms of Number of Developments in the singleplex immunoassay market
Key developments and growth strategies
New Product Launch/Service Deployment
Merger & Acquisitions
Joint Ventures
Major Players Financial Matrix
Sales and Operating Income
Major Players R&D Expenditure. 2023
Company Profiles
Fujirebio
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Eiken Chemical
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Mitsubishi Chemical
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Sysmex Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Tosoh Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Kyowa Medex
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Abbot Japan
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Roche Diagnostics K.K.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Appendix
References
Related Reports

COMPANIES MENTIONED
Fujirebio, Eiken Chemical, Mitsubishi Chemical, Sysmex Corporation, Tosoh Corporation, Kyowa Medex, Abbot Japan, Roche Diagnostics K.K.

ページTOPに戻る

List of Tables/Graphs

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 JAPAN SINGLEPLEX IMMUNOASSAY MARKET ANALYSIS BY PRODUCT AND SERVICE
FIGURE 3 JAPAN SINGLEPLEX IMMUNOASSAY MARKET ANALYSIS BY TYPE
FIGURE 4 JAPAN SINGLEPLEX IMMUNOASSAY MARKET ANALYSIS BY TECHNOLOGY
FIGURE 5 JAPAN SINGLEPLEX IMMUNOASSAY MARKET ANALYSIS BY APPLICATION
FIGURE 6 JAPAN SINGLEPLEX IMMUNOASSAY MARKET ANALYSIS BY END-USER
FIGURE 7 KEY BUYING CRITERIA OF SINGLEPLEX IMMUNOASSAY MARKET
FIGURE 8 RESEARCH PROCESS OF MRFR
FIGURE 9 DRO ANALYSIS OF JAPAN SINGLEPLEX IMMUNOASSAY MARKET
FIGURE 10 DRIVERS IMPACT ANALYSIS: JAPAN SINGLEPLEX IMMUNOASSAY MARKET
FIGURE 11 RESTRAINTS IMPACT ANALYSIS: JAPAN SINGLEPLEX IMMUNOASSAY MARKET
FIGURE 12 SUPPLY / VALUE CHAIN: JAPAN SINGLEPLEX IMMUNOASSAY MARKET
FIGURE 13 JAPAN SINGLEPLEX IMMUNOASSAY MARKET, BY PRODUCT AND SERVICE, 2024 (% SHARE)
FIGURE 14 JAPAN SINGLEPLEX IMMUNOASSAY MARKET, BY PRODUCT AND SERVICE, 2024 TO 2035 (USD Million)
FIGURE 15 JAPAN SINGLEPLEX IMMUNOASSAY MARKET, BY TYPE, 2024 (% SHARE)
FIGURE 16 JAPAN SINGLEPLEX IMMUNOASSAY MARKET, BY TYPE, 2024 TO 2035 (USD Million)
FIGURE 17 JAPAN SINGLEPLEX IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 (% SHARE)
FIGURE 18 JAPAN SINGLEPLEX IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
FIGURE 19 JAPAN SINGLEPLEX IMMUNOASSAY MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 20 JAPAN SINGLEPLEX IMMUNOASSAY MARKET, BY APPLICATION, 2024 TO 2035 (USD Million)
FIGURE 21 JAPAN SINGLEPLEX IMMUNOASSAY MARKET, BY END-USER, 2024 (% SHARE)
FIGURE 22 JAPAN SINGLEPLEX IMMUNOASSAY MARKET, BY END-USER, 2024 TO 2035 (USD Million)
FIGURE 23 BENCHMARKING OF MAJOR COMPETITORS

LIST OF TABLES
LIST OF ASSUMPTIONS
Japan SINGLEPLEX IMMUNOASSAY MARKET SIZE ESTIMATES; FORECAST
TABLE 1 BY PRODUCT AND SERVICE, 2026-2035 (USD Million)
TABLE 2 BY PRODUCT AND SERVICE, 2026-2035 (USD Million)
TABLE 3 BY TYPE, 2026-2035 (USD Million)
TABLE 4 BY TYPE, 2026-2035 (USD Million)
TABLE 5 BY TECHNOLOGY, 2026-2035 (USD Million)
TABLE 6 BY TECHNOLOGY, 2026-2035 (USD Million)
TABLE 7 BY APPLICATION, 2026-2035 (USD Million)
TABLE 8 BY APPLICATION, 2026-2035 (USD Million)
TABLE 9 BY END-USER, 2026-2035 (USD Million)
TABLE 10 BY END-USER, 2026-2035 (USD Million)
PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
ACQUISITION/PARTNERSHIP